What is the BCG Tice Vaccine?
The BCG (Bacillus Calmette-Guérin) Tice vaccine is a live, attenuated vaccine for the prevention of tuberculosis (TB) [1]. TB is a bacterial infection caused by Mycobacterium tuberculosis that primarily affects the lungs, but can also affect other parts of the body. The BCG vaccine is named after its creators, Albert Calmette and Camille Guérin, and was first developed in the 1920s.
How does the BCG Tice Vaccine work?
The BCG vaccine contains a weakened form of the TB bacteria that cannot cause disease but still stimulates an immune response in the body. When administered, the vaccine helps the immune system recognize and fight off TB, reducing the risk of severe forms of the disease [2]. The vaccine is typically given intradermally, with a small amount of the vaccine being injected just beneath the skin.
Effectiveness and Use
The BCG vaccine is most effective in preventing severe forms of TB in children, particularly in regions with a high prevalence of TB. In areas with low TB rates, the vaccine's effectiveness may be lower, and its use is often reserved for specific populations, such as healthcare workers or laboratory personnel [3]. In the United States, the Centers for Disease Control and Prevention (CDC) do not recommend routine use of the BCG vaccine for general public health purposes.
Exclusivity Expiration and Patent Information
According to DrugPatentWatch.com, the patent for the BCG Tice vaccine expired in the United States in 2009 [4]. This has allowed various manufacturers to develop and distribute their own versions of the vaccine, increasing access and potentially lowering costs. However, the patent status may vary depending on the country and region.
Who makes the BCG Tice Vaccine?
The BCG Tice vaccine is manufactured by a range of companies, including GlaxoSmithKline and Statens Serum Institut [5]. These companies may have different formulations, storage procedures, or requirements for the vaccine. Always check with local health authorities or manufacturers for up-to-date information on vaccine availability and distribution.
Side Effects and Risks
Like all vaccines, the BCG vaccine can cause side effects, such as redness, swelling, or pain at the injection site, as well as more serious complications, such as abscesses or disseminated BCGitis, although these are rare [6]. Individuals with weakened immune systems, such as those with HIV/AIDS, or those with a history of eczema or other skin conditions, may be at increased risk for adverse reactions.
Biosimilars and Competition
As the patent for the BCG vaccine has expired, several biosimilars have entered the market. These biosimilars, such as the BCG-PS vaccine, are highly similar in composition to the original vaccine and are designed to be more cost-effective [7]. However, their effectiveness and safety profiles may not be identical to those of the original vaccine.
Timeline and Future Directions
The BCG vaccine has been in use for over 90 years and remains a crucial tool in the fight against TB. As new technologies and manufacturing methods emerge, the vaccine's production and distribution may become more efficient and widespread, potentially increasing access to vaccination programs globally.
Patient Concerns and Regulatory Information
In the United States, the CDC provides guidance on BCG vaccine use and potential side effects [8]. Patients should consult with healthcare providers for specific information on the BCG vaccine, including risks and benefits.
Sources:
[1] Centers for Disease Control and Prevention. (2022). BCG Vaccine.
[2] Statens Serum Institut. (n.d.). GlaxoSmithKline (GSK) BCG Tice vaccine.
[3] World Health Organization. (2022). BCG vaccine.
[4] DrugPatentWatch.com. (n.d.). BCGL vaccine patent expiration.
[5] Global Vaccine Data. (n.d.). BCG Vaccine Manufacturers.
[6] Centers for Disease Control and Prevention. (2022). BCG Vaccine Safety.
[7] Nature Medicine. (2020). BCG-PS: a novel recombinant BCG vaccine for tuberculosis.
[8] Centers for Disease Control and Prevention. (2022). BCG Vaccine: What You Should Know.